Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CTI Class Action Stems From Management Dispute On PMA Submission Timing

This article was originally published in The Gray Sheet

Executive Summary

Alleged misrepresentations about the status of a pending premarket approval application for Computerized Thermal Imaging, Inc.'s BCS2100 breast cancer detection system are the subject of a recent 1shareholder class action lawsuit against CTI and former President and COO David Packer

You may also be interested in...



CTI class action dismissed

Portland, Ore. federal court dismisses class action against Computerized Thermal Imaging. The 2002 suit alleged misrepresentations about the status of a pending PMA for the BCS2100 breast cancer detection system by CTI and former President and COO David Packer (1"The Gray Sheet" June 24, 2002, p. 20). The court ruled that the statements "were either not material, not misleading, or not plead...with sufficient particularity," CTI says...

CTI class action dismissed

Portland, Ore. federal court dismisses class action against Computerized Thermal Imaging. The 2002 suit alleged misrepresentations about the status of a pending PMA for the BCS2100 breast cancer detection system by CTI and former President and COO David Packer (1"The Gray Sheet" June 24, 2002, p. 20). The court ruled that the statements "were either not material, not misleading, or not plead...with sufficient particularity," CTI says...

CTI BCS-2100 Breast Imaging System PMA Panel Review Set For Oct. 16

Computerized Thermal Imaging has lined up 27 U.S. and six international distributors for the launch of its BCS 2100 thermal breast imaging system following FDA approval

Latest Headlines
See All
UsernamePublicRestriction

Register

MT016761

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel